Abstract:Background: The precise genetic diagnosis of a sarcoglycanopathy or dystrophinopathy is sometimes extremely challenging, as pathogenic non-coding variants and/or complex structural variants do exist in DMD or sarcoglycan genes. This study aimed to determine the genetic diagnosis of three patients from two unrelated families with a suspected sarcoglycanopathy or dystrophinopathy based on their clinical, radiological, and pathological features, for whom routine genomic detection approaches failed to yield a definite genetic diagnosis. Methods: Muscle-derived reverse transcription-polymerase chain reaction analysis and/or TA cloning of DMD , SGCA , SGCB , SGCD , and SGCG mRNA were performed to identify aberrant transcripts. Genomic Sanger sequencing around the aberrant transcripts was performed to detect possible splice-altering variants. Bioinformatic and segregation studies of the detected genomic variants were performed in both families. Results: In patients F1-II1 and F1-II2, we identified two novel pathogenic compound heterozygous variants in SGCB . One is a deep intronic splice-altering variant (DISV), c.243 + 1558C > T in intron 2 causing the activation of an 87-base pair (bp) pseudoexon, and the other one is a non-canonical splicing site variant, c.243 + 6T > A leading to the partial intron inclusion of 10-bp sequence. A novel DISV, c.243 + 1576C > G causing a 106-bp pseudoexon activation, and a nonsense variant in SGCB were identified in compound heterozygous state in patient F2-II1. Unexpectedly, the predicted nonsense variant, c.334C > T in exon 3, created a new donor splice site in exon 3 that was stronger than the natural one, resulting in a 97-bp deletion of exon 3 (r.333_429del). Conclusion: This is the first identification of rare exonic and DISVs in the SGCB gene.

Splicing Characteristics of Dystrophin Pseudoexons and Identification of a Novel Pathogenic Intronic Variant in the DMD Gene

Splicing Characteristics of Dystrophin Pseudoexons and Identification of a Novel Pathogenic Intronic Variant in the <i>DMD</i> Gene

A new pseudoexon activation due to ultrarare branch point formation in Duchenne muscular dystrophy

Three novel splicing mutations at 5' terminal of DMD gene corresponding to different phenotypes

Skipping of an Exon with a Nonsense Mutation in the DMD Gene is Induced by the Conversion of a Splicing Enhancer to a Splicing Silencer.

Comprehensive Genetic Diagnosis of Patients with Duchenne/Becker Muscular Dystrophy (DMD/BMD) and Pathogenicity Analysis of Splice Site Variants in the DMD Gene

Functional Analysis of Variants in DMD Exon/intron 10 Predicted to Affect Splicing

Two Novel Deep Intronic Variants Cause Duchenne Muscular Dystrophy by Splice-Altering Mechanism

First Identification of Rare Exonic and Deep Intronic Splice-Altering Variants in Patients With Beta-Sarcoglycanopathy

A Novel Deep Intronic Variant Introduce Dystrophin Pseudoexon in Becker Muscular Dystrophy: A Case Report

Next-Generation Sequencing Detection and Characterization of A Heterozygous Novel Splice Junction Mutation in the 2b Domain of Krt1 in A Family with Diffuse Palmoplantar Keratoderma

RNA-seq analysis, targeted long-read sequencing and in silico prediction to unravel pathogenic intronic events and complicated splicing abnormalities in dystrophinopathy

Clinical, Muscle Imaging, and Genetic Characteristics of Dystrophinopathies with Deep-Intronic DMD Variants.

Cryptic Exon Activation Caused by a Novel Deep-Intronic Splice-Altering Variant in Becker Muscular Dystrophy.

Exonization of a Deep Intronic Long Interspersed Nuclear Element in Becker Muscular Dystrophy

Synonymous Variant at the Terminal Nucleotide in Exon 3 of F7 Causes Abnormal Splicing: A Case Report

Intron-targeted mutagenesis reveals roles for<i>Dscam1</i>RNA pairing-mediated splicing bias in neuronal wiring

Intron-targeted mutagenesis reveals roles for <i>Dscam1</i> RNA pairing architecture-driven splicing bias in neuronal wiring

Clinical and genetic interpretation of uncertain DMD missense variants: evidence from mRNA and protein studies

Comprehensive analysis of genomic complexity in the 5' end coding region of the DMD gene in patients of exons 1–2 duplications based on long-read sequencing

Long-Read Sequencing Revealed Extragenic and Intragenic Duplications of Exons 56–61 in DMD in an Asymptomatic Male and a DMD Patient